✦ LIBER ✦

Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder

✍ Scribed by Divya Bhagirath; Nitin Abrol; Rehan Khan; Manoj Sharma; Amlesh Seth; Alpana Sharma

Book ID: 116349556
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 581 KB
Volume: 413
Category: Article
ISSN: 0009-8981
DOI: 10.1016/j.cca.2012.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-6/10 Ratio as a Prognostic M

Interleukin-6/10 Ratio as a Prognostic Marker of Recurrence in Patients With Intermediate Risk Urothelial Bladder Carcinoma

✍ Cai, Tommaso; Mazzoli, Sandra; Meacci, Francesca; Tinacci, Galliano; Nesi, Gabri 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 266 KB

P36 Diagnostic and prognostic potential

P36 Diagnostic and prognostic potential of CK20 gene expression in patients with transitional-cell carcinoma of the urinary bladder

✍ P.K. Singh; A. Srivastava; P. Singh; D. Singh; D. Dalela; M. Goel; S. Gupta; M.P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Re: Association of Oncofetal Protein Exp

Re: Association of Oncofetal Protein Expression with Clinical Outcomes in Patients with Urothelial Carcinoma of the Bladder

✍ Szarvas, Tibor; Rübben, Herbert; Reis, Henning 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 115 KB

1716 HER-2 EXPRESSION STATUS PROVIDES IN

1716 HER-2 EXPRESSION STATUS PROVIDES INDEPENDENT PROGNOSTIC INFORMATION IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER

✍ Bolenz, Christian; Shariat, Shahrokh F.; Karakiewicz, Pierre I.; Ashfaq, Raheela 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

Expression of the polycomb group protein

Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder

✍ Stefan Hinz; Carsten Kempkensteffen; Frank Christoph; Michèle Hoffmann; Hans Kra 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 393 KB

Assessment of Serum CA 19.9 as a Tumour

Assessment of Serum CA 19.9 as a Tumour Marker in Patients with Carcinoma of the Bladder and Prostate

✍ P. D. ABEL; C. CORNELL; P. K. BUAMAH; GORDON WILLIAMS 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB